brand:
ACTEMRA®
manufacturer:
Genentech
active substances:
TOCILIZUMAB
strength:
400mg/20ml
pack size:
1 x 20ml Vial
ACTEMRA 400mg/20mL (Tocilizumab) is an intravenous monoclonal antibody that blocks IL-6 receptors to treat inflammatory conditions such as rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis, cytokine release syndrome, and severe COVID-19 pneumonia.